Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.
about
Chemotherapy for second-stage Human African trypanosomiasisImaging African trypanosomesGlossina fuscipes populations provide insights for human African trypanosomiasis transmission in UgandaParasitic diseases of the central nervous system: lessons for clinicians and policy makers.The death and life of the resurrection drugTrypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental ModelN¹,N¹-Dimethyl-N³-(3-(trifluoromethyl)phenethyl)propane-1,3-diamine, a new lead for the treatment of human African trypanosomiasis.Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaTreatment options for second-stage gambiense human African trypanosomiasis.Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein.African Trypanosomes Undermine Humoral Responses and Vaccine Development: Link with Inflammatory Responses?The animal trypanosomiases and their chemotherapy: a reviewIntegration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruziMetabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense infection.Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery.Congenital Trypanosomiasis in Child Born in France to African Mother.Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxides.Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity.Future treatment options for human African trypanosomiasis.A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.Repurposing Strategy of Atorvastatin against Trypanosoma cruzi: Monotherapy and Combined Therapy with Benznidazole Exhibit Synergistic Trypanocidal ActivityChallenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis
P2860
Q24201785-D3FA04C8-C097-4EEA-A61C-F2C0C0B9D4FBQ27010326-9879AB52-4056-44D2-91F3-0C446A325783Q27012611-A7FA3345-442D-4023-8157-381FFC79D78CQ28077177-5E6146DC-E96C-47CA-8FFE-2780AE852909Q28540609-75AFAA01-A33B-49EA-80B8-CB0137EC9C99Q28553573-117D8060-1B3B-4063-A2F9-9B57222EC689Q34975331-AC5A20FC-1ACA-42F5-A815-B1E70CF8EECBQ35049766-6BC21FBA-4D56-438D-828A-EAC5BD4C51CFQ35644191-FEDD400E-43E3-4693-968B-15BE5A46EAEAQ36551049-827EBF4F-4758-46C8-8C35-5CF5E79BE29CQ38495661-774627D4-11EA-4F06-8D40-D6726A86DE0CQ38735171-54951C35-0D90-40DE-8001-53E61025BEFBQ38975883-6D2BA7E0-E283-4EF1-8D5F-17C1D4096868Q39254761-A2971C81-0119-42DD-8D02-6D352C43763CQ40389286-462C571D-A421-48AB-B3E7-57D53B8CBAA9Q41996448-2B56AD5C-47B5-417F-B634-362B223897EDQ42163449-728ADCB5-685F-4F1F-A456-4FD4B443D22FQ42804550-3F83AEB3-54AE-4AE9-8E8B-5343A7D37A3BQ46338517-F3047F8F-9997-45F5-96D2-81570E717A0EQ46986753-D8210D84-F38C-4ADE-95F0-C7844A01D342Q48373153-6CCF0C7D-0A5A-4F0A-8A6E-2C51DF8509CEQ52689446-569C3DB9-FDB3-4AC8-8401-A6F7F899143DQ55322154-C288A3B4-4BA0-43AF-BDE9-3AE1408D23B2Q57167324-71EFC550-983D-4D44-BE36-7080B67DCF86Q57190987-4EAC07A8-4114-470F-993E-0BB4D24E9A06
P2860
Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nifurtimox-eflornithine combin ...... ocratic Republic of the Congo.
@en
Nifurtimox-eflornithine combin ...... ocratic Republic of the Congo.
@nl
type
label
Nifurtimox-eflornithine combin ...... ocratic Republic of the Congo.
@en
Nifurtimox-eflornithine combin ...... ocratic Republic of the Congo.
@nl
prefLabel
Nifurtimox-eflornithine combin ...... ocratic Republic of the Congo.
@en
Nifurtimox-eflornithine combin ...... ocratic Republic of the Congo.
@nl
P2093
P2860
P921
P356
P1476
Nifurtimox-eflornithine combin ...... ocratic Republic of the Congo.
@en
P2093
Andrea Riedel
Catherine de Patoul
David Schrumpf
Josué Amici Heradi
Michel Quere
P2860
P304
P356
10.1093/CID/CIS886
P407
P577
2012-10-16T00:00:00Z